 |
Peter Southern, Ph.D.
Associate Professor
Department of Microbiology
University of Edinburgh, Scotland, 1978, Ph.D.
south003@umn.edu
612-625-2141 office
612-625-2137 lab
|
Research Interests:
Human Retrovirus Transmission and Pathogenesis
I am interested in the cellular and molecular mechanisms underlying
virus transmission and the initiation of virus-induced diseases. After
working for many years with experimental infections of mice with an RNA
virus, lymphocytic choriomeningitis virus (LCMV), my research focus has
shifted recently to the study of infections with the human retroviruses,
human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia
virus types I and II (HTLV-I and HTLV-II). These retroviruses can be transmitted
either vertically or horizontally in human populations and we are beginning
to define essential parameters, in both the donor and recipient of infectivity,
that impact on the overall probability of transmission. Our experiments
are based on primary human cell populations, human organ cultures, and
body fluids from seropositive patients. Our goal is to develop manipulable
experimental systems that duplicate the natural routes for virus transmission.
More specifically, we are investigating the nature of HIV-1 infections
in male reproductive tissue to understand variability in the shedding
of HIV-1 infectivity in seminal fluid. In recipients, we are interested
in defining the mechanisms whereby HIV-1 infectivity can breach epithelial
barriers at mucosal surfaces and gain access to intraepithelial leukocytes
for the initiation and expansion of primary infections. New insight into
HIV transmission, with both cell-free and cell-associated HIV infectivity,
will be invaluable in refining vaccine studies and may contribute significantly
to the design of novel therapeutic agents to reduce the probability of
HIV transmission.
Selected Recent Publications:
- Maher, D., X. Wu, T. Schacker, M. Larson, and P. Southern. 2004. A model
system of oral HIV exposure utilizing human palatine tonsil reveals
extensive binding of HIV infectivity with limited progression to primary
infection. J. Infect. Dis. 190: 1989-1997. Abstract
Last modified on: September 6, 2005
|